Add BrightSurf on Google Email

Researchers suppress fibrosis chemical signal to block haywire healing

Researchers identified a key protein, SMAD3, that facilitates pro-fibrotic TGF-beta signaling. By blocking this protein, they created a peptide-carrying SNX9 that prevents SMAD3 from entering the nucleus and impacting genes regulated by TGF-beta. This approach may lead to effective treatments for fibrosis-related diseases.

SourceMayo Clinic·JournalJournal of Clinical Investigation·DateMay 22, 2017

Ebola survivors have a 'unique' retinal scar

Researchers found that around 15% of Ebola survivors have distinctive retinal scars, which appear specific to the disease but spare vision. The study also suggests that aqueous fluid analysis can help diagnose Ebola eye disease and enable access to cataract surgery for affected survivors

SourceUniversity of Liverpool·JournalEmerging Infectious Diseases·DateMay 15, 2017

Exploring the cause of chronic lung transplant rejection, in a quest to stop it

A new study by Michigan Medicine researchers found that cells from lung transplant patients with bronchiolitis obliterans syndrome (BOS) can become activated and promote scarring. The team identified a chain of upstream signals starting with autotaxin, an enzyme that generates lysophosphatidic acid, which stimulates collagen production.

SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Investigation·DateMar 1, 2017

Unveiling the biology behind nonalcoholic fatty liver disease

Researchers at EPFL have identified a key player in the development of nonalcoholic fatty liver disease (NAFLD), a condition characterized by excessive fat accumulation in the liver. The study found that impaired SUMOylation of nuclear receptor LRH-1 promotes NAFLD, highlighting potential new treatments and biomarkers for the disease.

SourceEcole Polytechnique Fédérale de Lausanne·JournalJournal of Clinical Investigation·DateJan 17, 2017

Stopping scars before they form

Researchers have identified a potential treatment for severe scarring by inhibiting an enzyme called lysyl oxidase, which enables collagen to crosslink and form scar tissue. The compounds, tested in a 'scar-in-a-jar' model, show promise in restoring normal tissue architecture.

The Lancet Neurology: Scientists discover unique pattern of hidden brain damage in male soldiers exposed to high explosive blasts

Researchers found a distinctive pattern of injury in the brains of deceased military personnel who survived high explosive attacks, suggesting a link between blast exposure and neuropsychiatric symptoms. The study's findings highlight the need for further research to understand the underlying pathophysiology of traumatic brain injury.

SourceThe Lancet·JournalThe Lancet Neurology·DateJun 9, 2016

Combination of cells and genes repairs damaged heart tissues in animal models of MI

Researchers have discovered a combination of cells and genes that can repair damaged heart tissues in animal models of myocardial infarction. The study found that different biological treatments target various aspects of cardiac function and scarring, with some showing significant improvements in contractile function and angiogenesis.

Newfound strength in regenerative medicine

Researchers at the Wyss Institute have discovered that cyclic mechanical stimulation can improve muscle regeneration and reduce scarring, opening doors for new non-biologic therapies. The study used murine models of muscle injury and found a two-and-a-half-fold improvement in muscle regeneration with both magnetized gel and robotic cuf...

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalProceedings of the National Academy of Sciences·DateJan 25, 2016

Fighting liver fibrosis, the wound that never heals

The Salk Institute has identified a drug called JQ1 that prevents and reverses liver fibrosis in animals, a condition that replaces normal liver cells with scar tissue until the organ no longer works. This discovery may also treat fibrosis in other organs such as the lung, pancreas, and kidney.

SourceSalk Institute·JournalProceedings of the National Academy of Sciences·DateDec 8, 2015